Source: International Congress 2016 – Immune responses in the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Takashi Ishii (Tokyo, Japan), Takashi Ishii, Keisuke Hosoki, Yuichi Nikura, Takahide Nagase, Naomi Yamashita. Essential role of IRF-3 in COPD exacerbation mouse model. Eur Respir J 2016; 48: Suppl. 60, 3638

Member's Comments

No comment yet.

Related content which might interest you: Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Targeting IL33-ST2 pathway in virus-induced exacerbation of experimental asthma Source: International Congress 2016 – Immune responses in the lung Year: 2016 The role of Clara cell senescence in the pathogenesis of COPD Source: International Congress 2014 – Effect of cigarette smoke on cell behaviour: cell biology, signalling and senescence Year: 2014 The role of lL-17 in the OVA-LPS driven model of lung inflammation Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Autoimmune induction of a COPD-like inflammatory phenotype in mice Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Lung inflammation: The role of alveolar macrophages Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 IL33 and TSLP involvements in influenza-induced exacerbation in a murine model of chronic asthma Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 CD39 deficiency results in increased inflammation in an animal model of pulmonary fibrosis Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Acid sphingomyelinase deficiency improves lung function in allergen-induced asthma in mice Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Modeling human pulmonary inflammatory diseases and therapeutic responses in a microfluidic lung airway-on-a-chip Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Crucial timing of a viral component exposure to exacerbate allergen-induced asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease Source: International Congress 2014 – Cell biology 2014 Year: 2014 Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Standardization of a murine model of asthma due to soybean inhalation Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 A short-term model of COPD identifies a role for mast cell tryptase Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Immunomodulatory role of IL-37 in asthma pathogenesis Source: International Congress 2016 – Immune responses in the lung Year: 2016 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Systemic inflammatory response to smoking in chronic obstructive pulmonary disease: Evidence of a gender effect Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014